Clinical Trials on Carcinoma, Bronchogenic in New Zealand
Total 4047 results
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnBuparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Adult Solid NeoplasmUnited States
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Taiwan, Italy, Singapore, Austria, Canada, France, Germany, Japan, Korea, Republic of, Mexico, Poland, Spain
-
Eli Lilly and CompanyTerminatedSmall Cell Lung CarcinomaUnited States, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Small Cell Lung CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | NSCLC, Stage III | Nsclc | NSCLC Stage IIUnited States
-
AbbottTerminatedNon-Small Cell Lung Cancer | Lung CancerUnited States, Canada, Ireland, United Kingdom
-
Hoosier Cancer Research NetworkEli Lilly and Company; Walther Cancer InstituteTerminatedSmall Cell Lung CancerUnited States
-
EpicentRx, Inc.TerminatedCarcinoma, Small Cell LungUnited States
-
EMD SeronoCompletedLung Cancer | Non Small Cell Lung CarcinomaUnited States, Germany, Austria
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States, Canada, Korea, Republic of, Mexico
-
CytRxWithdrawn
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Taiwan
-
ImmunoGen, Inc.CompletedSmall Cell Lung CancerUnited States
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
StemcentrxCompletedSmall Cell Lung CarcinomaUnited States, Canada
-
Spectrum Pharmaceuticals, IncTerminatedNSCLCUnited States, Canada, Netherlands, Belgium, Israel, Spain, France, Italy
-
Sunesis PharmaceuticalsCompletedSmall Cell Lung Cancer | Carcinoma, Small CellUnited States, Canada
-
PfizerCompletedAdenocarcinoma | Non-Small-Cell Lung CarcinomaUnited States, Spain, Poland, Czech Republic, United Kingdom, France
-
OBI Pharma, IncRecruiting
-
GlaxoSmithKlineCompletedSmall Cell Lung CancerUnited States, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Costa Rica, Czech Republic, Estonia, Finland, France, Germany, Honduras, Hungary, Italy, Jamaica, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Norw... and more
-
TakedaActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Spain, Korea, Republic of, Taiwan, Japan, China, Italy, Germany, United Kingdom, Puerto Rico
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Turkey
-
NRG OncologyNational Cancer Institute (NCI); Radiation Therapy Oncology GroupActive, not recruitingExtensive Stage Small Cell Lung Carcinoma | Limited Stage Small Cell Lung CarcinomaUnited States, Canada
-
Hoosier Cancer Research NetworkGenentech, Inc.; Walther Cancer InstituteCompletedSmall Cell Lung CancerUnited States
-
Famewave Ltd.TerminatedMelanoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Bladder Cancer | Non-small Cell Lung Carcinoma (NSCLC)United States, Israel
-
National Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Platinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Lale KostakogluTerminatedNeuroendocrine Tumors | Carcinoid TumorsUnited States
-
Case Comprehensive Cancer CenterSmith Kline BeechamCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedExtensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompletedMelanoma | Non-Small Cell Lung Cancer | Advanced CancerCanada, United States, Australia, France, Italy, Spain, Finland, Germany, Norway, Poland, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedLung CancerUnited States, Puerto Rico, South Africa
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
Cell>Point LLCVenn Life Sciences; Numoda; Camargo Pharmaceutical Services; Biomedical ServicesCompletedNon Small Cell Lung CancerUnited States, Canada
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
AkesoChipscreen Biosciences, Ltd.RecruitingSCLC,Extensive StageAustralia, China
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerAustralia, Germany, United States
-
Peregrine PharmaceuticalsCompletedNon-small Cell Lung CancerIndia
-
PfizerTerminatedCarcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Carcinoma, Adenosquamous | Carcinoma, Large CellUnited States, Bulgaria, Canada, Ukraine, Greece, Austria, France, Korea, Republic of, Poland, Russian Federation, Spain, Turkey, Finland, Hungary, Taiwan, Italy, Japan, Australia, Germany, Brazil, India, Puerto Rico, Czech Republic, ... and more
-
Tragara Pharmaceuticals, Inc.CompletedRecurrent Non Small Cell Lung CancerUnited States
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerCanada, Belgium, Korea, Republic of, United States, France, Brazil, China, New Zealand, Israel, Spain, Argentina, Serbia, Mexico, Italy, Japan, Turkey, Taiwan, Costa Rica, Thailand, Australia, Germany, Hong Kong, Netherlands, Peru, Poland, Russian Federation and more
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaboratorsTerminatedSmall Cell Lung CancerUnited States, Taiwan, Germany, Belgium, United Kingdom
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Brazil, United Kingdom, China, Israel, Australia, Belgium, Netherlands, Argentina, Spain, Taiwan, Canada, Italy, Poland, Turkey, Sweden, Switzerland
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
Greg Durm, MDAstraZeneca; Indiana University School of MedicineTerminatedNon Small Cell Lung Cancer | Stage III Non-small-cell Lung CancerUnited States
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation